NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.19
0.02 (1.71%)
At close: Aug 15, 2025, 3:49 PM
1.71% (1D)
| Bid | 1.19 |
| Market Cap | 29.28M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.21M |
| EPS (ttm) | -0.36 |
| PE Ratio (ttm) | -3.31 |
| Forward PE | -6.45 |
| Analyst | Hold |
| Ask | 1.21 |
| Volume | 168,261 |
| Avg. Volume (20D) | 374,632 |
| Open | 1.15 |
| Previous Close | 1.17 |
| Day's Range | 1.15 - 1.20 |
| 52-Week Range | 0.67 - 2.60 |
| Beta | 1.62 |
About NRSN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRSN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+12.28%
NeuroSense Therapeutics shares are trading higher....
Unlock content with
Pro Subscription
8 months ago
+14.27%
NeuroSense Therapeutics shares are trading higher after the company announced its CEO purchased $5 million worth of ordinary shares in a private placement.
